![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 41, 29323-29330, October 8, 1999
From the Laboratory of Biological Chemistry, Gerontology Research Center, NIA, National Institutes of Health, Baltimore, Maryland, 21224-6825
| |
ABSTRACT |
|---|
|
|
|---|
The Tec family tyrosine kinase, Itk has been
implicated in T cell antigen receptor (TCR) signaling, yet little is
known about Itk regulation. Here, we investigate the role of the
tyrosine kinase ZAP-70 in regulating Itk. Whereas Itk was activated in Jurkat T cells in response to CD3 cross-linking, Itk activation was
defective in the ZAP-70-deficient P116 Jurkat T cell line. Itk
responsiveness to TCR engagement was restored in P116 cells stably
transfected with ZAP-70 cDNA. ZAP-70 itself could not directly phosphorylate the Itk kinase domain, indicating an indirect regulation of Itk activity. No role was found for ZAP-70 in regulating Itk recruitment to the plasma membrane, an event that has been suggested to
be rate-limiting for the activation of Tec family kinases. Indeed, Itk
was found to be constitutively targeted to the membrane fraction in
both Jurkat and P116 cells. Lat, a prominent in vivo substrate of ZAP-70 that mediates assembly of multimolecular signaling complexes at the plasma membrane of T cells was also found to be
required for TCR-stimulated Itk activation. Itk could not be activated
by CD3 cross-linking in a Lat-negative cell line, unless Lat expression
was restored. Lat and Itk were observed to co-associate in response to
CD3 cross-linking in Jurkat T cells, but not in P116 T cells. The
Lat-Itk association correlated with Lat tyrosine phosphorylation, which
was deficient in the P116 T cells. These data suggest that ZAP-70 and
Lat play important, probably sequential, roles in regulating the
activation of Itk following TCR engagement.
Engagement of the T cell antigen receptor
(TCR)1 initiates a complex
cascade of biochemical events, which, in the context of co-stimulatory
signals, culminate in proliferation and acquisition of effector
functions by the T cell. The most receptor-proximal events initiated
upon TCR stimulation are the activation of several protein tyrosine
kinases (PTKs) of the Src, Syk, and Tec families (1, 2). TCR signaling
is initiated when the Src family PTKs Lck and Fyn phosphorylate
specific tyrosine residues within the immunoreceptor tyrosine-based
activation motifs of the CD3 ( ZAP-70 lies at a key point in the TCR signaling pathway, being required
for the activation of calcium mobilization and Erk activation pathways,
which are in turn required for interleukin-2 production and T cell
proliferation (7, 8). This function is accomplished, in part, by
regulating the formation of certain key multimolecular signaling
complexes involved in these pathways, by catalyzing the phosphorylation
of the hematopoietic-specific proteins SLP-76 and Lat (9-11). Both of
these proteins have been shown to be in vivo substrates of
ZAP-70 (12-14). SLP-76, when tyrosine-phosphorylated, binds to another
hematopoietic-specific protein, Vav, and has been implicated in playing
an important, as yet undefined role in both Ca2+
mobilization as well as Ras activation in T cells (12, 15, 16).
Tyrosine-phosphorylated Lat, which is primarily resident in the
glycolipid-enriched membrane (GEM) fraction of the plasma membrane,
recruits PLC The Tec family tyrosine kinases have been implicated in antigen
receptor signaling in a variety of hematopoietic cell types. Btk, a Tec
family member primarily expressed in B cells and mast cells, is
involved in B cell antigen receptor signaling and was found to be
defective in the human and murine immunodeficiencies, X-linked
agammaglobulinemia, and X-linked immunodeficiency, respectively (21-23). Itk, also known as Emt or Tsk, is expressed in T cells and NK
cells (24-26); is tyrosine-phosphorylated in response to cross-linking
of TCR, CD28, or CD2 (27-29); and has been implicated in thymocyte
development and the activation of T cells through TCR and CD28
engagement. Mice engineered with a null mutation within the Itk gene
have decreased numbers of mature thymocytes. Furthermore, T cells
isolated from these mice are compromised in their proliferative
response to allogeneic MHC stimulation, and to anti-TCR/CD3
cross-linking (30). These T cells also exhibit defective PLC How Itk activity is regulated in response to TCR engagement is still
poorly understood. Structural studies have shown that Itk forms
intramolecular interactions between its Src homology 3 domain and the
proline-rich region of its Tec homology domain, and it has been
proposed that these associations may be involved in regulating its
activity (32). Experiments in Jurkat T cells lacking Lck have
demonstrated a requirement for Lck in Itk activation in response to TCR
engagement (28). Lck has also been shown to phosphorylate the critical
activation loop tyrosine of Itk in vitro (33). The
activation of Itk by G protein These latter studies by August et al. (35) and Scharenberg
et al. (36) are consistent with the recently proposed model that Tec family kinases possessing pleckstrin homology domains (Itk/Tsk/Emt, Btk, and Tec) are regulated by changes in their subcellular localization. This model holds that receptor engagement activates PI3-K, which raises the plasma membrane concentration of
phosphatidylinositol 3,4,5-trisphosphate, which is a high affinity binding site for the Tec family pleckstrin homology domain (37). This
results in recruitment of Tec family kinases to the plasma membrane,
where they are phosphorylated and activated by membrane-resident Src
family kinases. Most of the evidence supporting this model has been
gathered by study of Btk regulation (36, 38-40). Testing this model in
Jurkat T cells, we found no evidence for TCR-stimulated Itk recruitment
to the plasma membrane. Indeed, Itk was found to be constitutively
present in the membrane fraction. In unstimulated Jurkat T cells, Itk
could be recovered from both the GEM and bulk membrane fractions, and
neither fraction exhibited any change in the Itk level upon TCR
stimulation, arguing against redistribution of Itk to the plasma
membrane as a mechanism for activation in Jurkat T cells. We also
examined the role of ZAP-70 in Itk activation by measuring Itk
activation in the ZAP-70-deficient P116 T cell line. We found that
ZAP-70 is required for phosphorylation of Itk and activation of its
kinase activity. However, ZAP-70 was unable to directly phosphorylate
the kinase domain of Itk, suggesting that the role of ZAP-70 in
regulating Itk tyrosine phosphorylation and activation is indirect. We
also report the TCR-stimulated association of Itk with Lat, which was
only observed in ZAP-70 replete cells. This association occurs with the
same kinetics as Itk tyrosine phosphorylation and activation, and seems
to be required for Itk activation in response to CD3 cross-linking, because OKT3-induced Itk activation was markedly reduced in
Lat-deficient JCaM2.5 cells.
Cells and Antibodies--
The ZAP-70 deficient Jurkat T cell
line, P116, has been previously described (8, 41). P116 and the
parental Jurkat E6 cells were the kind gift of R. Abraham (Duke
University, Durham, NC). P.WT.18, a gift of L. Samelson (NCI, National
Institutes of Health, Bethesda, MD), is a stable transfectant of P116
that expresses Myc-tagged, wild type ZAP-70 at a level comparable to the parental Jurkat line and has been characterized previously (41,
42). The Lat-deficient Jurkat T cell mutant JCaM2.5 (43) and its
Lat-reconstituted cell line,
JCaM2.5B32 have been
described and are the kind gifts of A. Weiss (University of California,
San Francisco, CA) and L. Samelson (NCI, National Institutes of Health,
Bethesda, MD). The JCaM2.5 cells show intact early signaling events,
including tyrosine phosphorylation of CD3 chains and tyrosine
phosphorylation and activation of ZAP-70, indicating that the Src
family kinases Lck and Fyn function normally in these cells (43). All
cells were maintained in RPMI 1640 medium supplemented with 7.5% fetal
bovine serum (Hyclone), 10 µg/ml ciprofloxacin (Bayer), and 2 mM glutamine. The OKT3 monoclonal antibody to human CD3 and
polyclonal rabbit antisera specific for human ZAP-70 and Lck have been
described (6). The anti-phosphotyrosine monoclonal antibody, 4G10 was
from Upstate Biotechnology, Inc. (Lake Placid, NY). A polyclonal rabbit
antiserum specific for human Itk was used to immunoprecipitate Itk and
was kindly provided by G. Mills (University of Texas M. D. Anderson
Cancer Center, Houston, TX). Itk was immunoblotted with the monoclonal
antibody 2F12 directed against the N-terminal 26 amino acids of Itk,
which was the gift of L. Berg (University of Massachusetts, Worcester, MA). The cytosolic domain of band III protein (cdb3) was prepared as
described previously (44). GST fusion proteins containing the kinase
domain of either Itk or Lck were the kind gift of J. Watts and R. Aebersold (University of Washington, Seattle, WA) and have been
previously described (45).
Cell Stimulation and Lysis--
Cells were harvested by
centrifugation, washed once, and resuspended in cold RPMI 1640 medium
at a density of 1 × 108 cells/ml. After equilibration
to 37 °C for 10 min, the cells were stimulated with OKT3 (1:50
ascites) for the indicated duration. Stimulation was terminated by
addition of 5 volumes of 4 °C lysis buffer (20 mM Hepes
(pH 7.4), 1% Triton X-100, 50 mM Immunoprecipitation and Western Blotting--
The postnuclear
whole-cell lysates were incubated with protein A-agarose beads and
corresponding antibodies for 2-16 h at 4 °C. In some of the
anti-Itk immunoprecipitations, ZAP-70, Lck, and other TCR-associated
proteins were depleted from the lysates by three rounds of OKT3 and/or
anti-Lck immunoprecipitation. Immunoprecipitates that were to be
analyzed by immunoblotting were washed three times with the above lysis
buffer supplemented with 150 mM NaCl. Whole-cell lysates
and immunoprecipitates to be analyzed by Western blotting were
denatured by heating to 100 °C in Nu-PAGE sample buffer, electrophoresed on either 4-12% Nu-PAGE gradient or 6% Tris-glycine gels, and transferred to nitrocellulose membrane according to manufacturer's instructions (NOVEX, San Diego, CA). The blots were
developed with the ECL system of Amersham Pharmacia Biotech and
autoradiographed on BMR film (Eastman Kodak Co.).
In Vitro Itk Kinase Assay--
Itk-associated tyrosine kinase
activity was assessed by immune complex kinase assay. Anti-Itk
immunoprecipitates from lysates depleted of CD3 (and CD3-associated
proteins) and Lck were washed twice with lysis buffer + 150 mM NaCl, twice with 4 °C LiCl wash buffer (100 mM Tris-HCl (pH 7.5), 0.5 M LiCl) and twice
with 4 °C dH2O. To each sample of washed beads 30 µl
of kinase reaction mixture (10 mM MgCl2, 10 mM Hepes (pH 7.0), 2 mM sodium orthovanadate, 5 µCi of [ In Vitro Phosphorylation of Itk Kinase Domain (Itk-KD) and
Cdb3--
The kinase reaction was carried out at 30 °C for 10 min
in a total volume of 30 µl of reaction buffer (50 mM
Tris-HCl (pH 7.5), 10 mM MnCl2, 50 µM ATP, and 10 µCi of [ Preparation of Cytosolic and Membrane Fractions--
Cells
(2.5 × 107) were centrifuged quickly in cold
phosphate-buffered saline after OKT3 stimulation and resuspended in 1.5 ml of cold hypotonic lysis solution (20 mM Hepes (pH 7.6),
5 mM sodium pyrophosphate, 5 mM EGTA, 1 mM MgCl2, 10 µg/ml aprotinin, 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride), 1 mM sodium orthovanadate). The cell suspension sat on ice
for 30 min, followed by cellular disruption with 10 passes of a Dounce
homogenizer. After centrifugation at 100,000 × g at
4 °C for 1 h, the supernatant was collected as the cytosolic
fraction. The pellet was rinsed with cold hypotonic lysis buffer and
solubilized in 1.5 ml of the membrane solubilization solution (1%
Triton X-100, 20 mM Hepes (pH 7.4), 150 mM
NaCl, 1 mM MgCl2, 1 mM
4-(2-aminoethyl)-benzenesulfonyl fluoride), 1 mM sodium
orthovanadate) on ice for 30 min, followed by centrifugation at
100,000 × g at 4 °C for 1 h. This supernatant
was taken as the membrane fraction.
Purification of GEM Fractions--
Cells (1 × 108) were centrifuged quickly in cold phosphate-buffered
saline after OKT3 stimulation. The pellets were then lysed on ice in 1 ml of 1% Triton X-100 in TNEV buffer (10 mM Tris-HCl (pH
7.5), 150 mM NaCl, 5 mM EDTA, 1 mM
Na3VO4), with 15 strokes of a Dounce
homogenizer, and mixed with 1 ml of 80% sucrose made with TNEV buffer.
After transfer of the lysate to the centrifuge tube, 2 ml of 30%
sucrose in TNEV buffer was overlaid, and then 1 ml of 5% sucrose in
TNEV was overlaid. After centrifugation for 17 h at 200,000 × g in a Beckman SW55Ti, 0.4-ml gradient fractions were
collected from the top of the gradient, in which the third fraction
contained GEMs.
ZAP-70 Is Required for Tyrosine Phosphorylation and Activation of
Itk in Response to CD3 Cross-linking--
To study the importance of
ZAP-70 in Itk activation during TCR signaling, the human T cell line
Jurkat and its ZAP-70-deficient mutant P116 were stimulated by CD3
cross-linking. As has been shown previously (28, 33) and in the
top panel of Fig.
1A, Itk was rapidly
tyrosine-phosphorylated in Jurkat T cells upon OKT3 stimulation.
Tyrosine phosphorylation could be detected within 45 s and
returned to basal level by 15 min. In contrast, there was comparatively
little increase in tyrosine phosphorylation of Itk in ZAP-70-negative
cells receiving the same stimuli. The difference in Itk tyrosine
phosphorylation in the two cell lines was not due to differences in Itk
recovery, as the immunoprecipitates contained comparable amounts of Itk
(Fig. 1A, bottom panel).
In the same experiment, we also examined whether or not ZAP-70 could
regulate increased Itk kinase activity in response to TCR
cross-linking. We compared the Itk kinase activity in both Jurkat and
P116 cells, as measured by 32P incorporation into the
substrate RR-SRC in an in vitro, immune-complex kinase assay
(Fig. 1B). OKT3 stimulation induced a rapid increase in the
kinase activity recovered from Itk immunoprecipitates from Jurkat
cells, but not in Itk immunoprecipitates from similarly treated
ZAP-70-deficient P116 cells. Equal amounts of Itk were detected in the
immunoprecipitates (Fig. 1A, bottom panel). Although one
group has reported that RR-SRC is not a good substrate for recombinant
Itk (33), others have reported the peptide to be a suitable substrate
(28), and we find RR-SRC to be a good substrate for both
immunoprecipitated and recombinant (not shown) Itk. In particular, it
is unlikely that the kinase activity measured in this assay is subject
to interference from ZAP-70 or Lck, because RR-SRC is not a ZAP-70
substrate under the assay conditions used, and depletion of Lck from
the lysates had no effect upon the OKT3-mediated activation of kinase
activity recovered in Itk immunoprecipitations (not shown).
To test whether the failure of tyrosine phosphorylation and subsequent
kinase activation of Itk in P116 cells following TCR stimulation is due
to the absence of ZAP-70, we examined the phosphorylation and
activation of Itk in P.WT18 cells. This stable transfectant of P116 has
been characterized previously, and expresses ZAP-70 at levels
comparable to those observed in Jurkat (Fig.
2B, top panel, and Refs. 41
and 42). As seen in Fig. 2A, upon stimulation with OKT3, Itk
kinase activity in the P.WT18 cells increased 2.7-fold, exhibiting a
similar fold increase in activity as that elicited by similarly
stimulated parental Jurkat T cells (2.9-fold). P116 cells, on the other
hand, had poor Itk activation in response to CD3 cross-linking,
exhibiting only a 1.1-fold increase in the kinase activity. No kinase
activity was observed in the control normal rabbit serum
immunoprecipitations. Equal amounts of Itk were used in the kinase
assay for all three cell lines (not shown). The restoration of the
responsiveness of Itk kinase activity to CD3 cross-linking correlated
with restoration of OKT3-stimulated tyrosine phosphorylation of Itk
(Fig. 2B, bottom panel). These results indicate that the
defect in Itk activation in P116 cells can be restored by expression of
ZAP-70.
ZAP-70 PTK Acts Indirectly in Regulating Itk Tyrosine
Phosphorylation--
Most protein kinases undergo activation in
response to phosphorylation of key residues present within the
activation loop of the kinase domain. Itk is no exception, and it has
been shown to be positively regulated in response to phosphorylation of
tyrosine 511 within its activation loop (33). That this is the
principal site of tyrosine phosphorylation-dependent
positive regulation of Itk kinase activity has been demonstrated by
expression of wild type and Y511F mutant Itk in insect cells. Insect
cells expressing wild type Itk show extensive tyrosine phosphorylation
of multiple cellular substrates, whereas cells expressing Itk carrying
the Y511F mutation do not (33). It is likely therefore that, if the
positive regulatory effect of ZAP-70 upon Itk activity were due to
direct phosphorylation, Tyr-511 would be the site of phosphorylation in
Itk. We therefore tested the ability of the KD of Itk to serve as a
substrate for ZAP-70 (Fig. 3). The Itk
kinase domain used in this experiment had low intrinsic autocatalytic
activity under the conditions used in the assay, allowing us to study
the ability of either recombinant Lck or immunoprecipitated ZAP-70 to
phosphorylate the Itk kinase domain. Although ZAP-70 could
phosphorylate cdb3, a protein previously demonstrated to be a good
substrate for ZAP-70, it did not phosphorylate the Itk-KD. Lck, on the
other hand, was able to phosphorylate the Itk kinase domain, but not
cdb3. Lck also exhibited considerable autophosphorylation. In the
absence of added kinase, cdb3 was not phosphorylated in the assay.
Under the conditions of the assay, ZAP-70 showed little
autophosphorylation. The absence of recognizable ZAP-70 phosphorylation
sites within Itk, and the inability of ZAP-70 to phosphorylate the Itk
kinase domain in vitro suggest that ZAP-70 acts indirectly
to stimulate Itk tyrosine phosphorylation and activation. However, our
data do not allow us to rule out the possibility of Itk being
phosphorylated by ZAP-70 on tyrosine residues outside its kinase
domain, nor that ZAP-70 could phosphorylate Itk in vivo.
Itk Is Constitutively Located in the Glycolipid-enriched Region of
the Plasma Membrane--
Finding no evidence that ZAP-70 was directly
phosphorylating and activating Itk, we examined whether or not ZAP-70
was regulating the subcellular distribution of Itk, because it had been
previously proposed that Tec family tyrosine kinases can be activated
in response to recruitment to the plasma membrane (35, 36, 38-40, 46).
Jurkat and P116 T cells were either left unstimulated or stimulated by
45 s of CD3 cross-linking, conditions that give maximal Itk
tyrosine phosphorylation and activation. Triton X-100 extracts of
cytosolic and membrane fractions were immunoblotted for Itk (Fig.
4A, top panel). A portion of
the lysates were subjected to Itk immunoprecipitation and also blotted
for Itk (Fig. 4A, bottom panel). Itk was constitutively
present in both the cytosolic and membrane fractions, with
approximately 50% of the Itk being present in the membrane. This is in
stark contrast to the distribution pattern that has been reported for
Btk in bone marrow-derived mast cells, in which it was found that
greater than 95% of the Btk is present in the cytosolic fraction (38).
Because the Itk recovered from unstimulated Jurkat T cells has minimal
activity, yet roughly half of the total Itk is constitutively present
in the membrane fraction, distribution into the membrane fraction does
not appear to be the rate-limiting event in Itk activation in Jurkat T
cells. This is in contrast to what has been reported for Btk activation
in B cells and mast cells. Furthermore, we could detect no measurable
net redistribution between the two pools upon OKT3 stimulation. A
similar pattern was also observed in unstimulated and OKT3-stimulated
P116 cells.
It remained possible that although CD3 cross-linking in Jurkat T cells
did not result in a gross translocation of Itk from the cytosol to the
plasma membrane, perhaps CD3 cross-linking caused a redistribution of
Itk between compartments within the plasma membrane itself. It has
recently been recognized that the plasma membrane is not uniform, but
rather contains lateral domains that differ in composition from bulk
plasma membrane. These domains are typified by high concentrations of
certain lipids, including cholesterol, glycosphingolipids,
sphingomyelin, and phosphatidylinositol 4,5-bisphosphate, although
being relatively poor in other phospholipids. These domains are
resistant to disruption in nonionic detergents at 4 °C, and have
been referred to as lipid rafts, detergent-insoluble membranes (DIGs)
or glycolipid-enriched membranes (GEMs) (47, 48). These domains also
contain a high concentration of glycosyl phosphatidylinositol-linked
proteins and several key signaling molecules, and it has been suggested
that these membrane regions serve as signaling rafts or nodes. In T
cells, Fyn, Lck, Lat, c-Cbl, CD4, and Ras have been reported to be
constitutively targeted to the GEMs, whereas TCR chains, ZAP-70, Shc,
PLC Lat Is Required for OKT3-stimulated Itk Activation--
Lat is a
recently described T cell- and NK cell-specific transmembrane
phosphoprotein that is thought to play a key role as a transmembrane
linker protein involved in TCR signaling. Lat has also been reported to
be an in vivo substrate for ZAP-70 and rapidly becomes
tyrosine-phosphorylated in response to TCR engagement, whereupon it
acts as a docking site for key signaling proteins, such as Grb2, Grap,
PLC CD3 Cross-linking Induces an Association between Itk and
Tyrosine-phosphorylated Lat--
Given an apparent role for Lat in
regulating Itk activation, and the established role of Lat in forming
multimolecular signaling complexes, we assessed whether or not we could
measure a TCR stimulation-induced association between Itk and Lat in
Jurkat T cells. Examining by anti-Itk immunoblot the presence of Itk in
anti-Lat immunoprecipitations from Brij96 whole-cell lysates of
OKT3-stimulated or unstimulated Jurkat and P116 T cells, we found that
CD3 cross-linking induced a rapid association between Lat and Itk in
Jurkat T cells, but not in the ZAP-70-negative P116 T cells (Fig.
6A, top panel). This
observation is also consistent with the report of Zhang et al. (14) who, in addition to noting the OKT3-stimulated
association of tyrosine-phosphorylated PLC
It should be noted that it has been shown that the mutual
co-localization of proteins to the Triton-insoluble GEMs can permit co-precipitation of proteins even when there is no direct interaction between the proteins. Indeed, glycosyl phosphatidylinositol-anchored proteins are co-precipitated with Fyn and Lck in Triton X-100 lysates
of T cells, despite the fact that glycosyl phosphatidylinositol-linked proteins only attach to the outer leaflet of the plasma membrane and
Fyn and Lck only associate with the inner leaflet (50-52). However, it
seems unlikely that the co-immunoprecipitation of Itk with Lat from
Brij96 lyastes of OKT3-stumlated Jurkat that we report here results
from such a mechanism. First of all, we also observe the
anti-CD3-induced association of Itk with Lat in Octylglucoside
extracted GEM fractions (not shown), under conditions demonstrated to
disrupt greater than 90% of the GEMs (49, 52). Second, we could detect
no change in the amount of Itk or Lat present in the GEMs upon OKT3
stimulation nor any significant differences between the two cell lines
in the amount of Itk or Lat in the GEM fractions. This being so,
GEM-mediated co-immunoprecipitation would be predicted to give the same
amount of co-immunoprecipitation from both cell lines, regardless of
OKT3 stimulation, which clearly is not what was observed.
Relevant to our observation of constitutive localization of Itk to the
membrane fraction in Jurkat T cells, a GFP-Itk fusion protein expressed
in Jurkat TAg T cells was also found to be constitutively associated
with the plasma membrane and exhibited no detectable redistribution
upon TCR stimulation.3
Furthermore, two recent studies examining the effect of knocking out
the
It is possible that the phenomenon of constitutive Itk association with
the membrane may be a peculiarity of the transformed phenotype of
Jurkat T cells, and it remains to be established whether the same
pattern is observed in normal T cells. Interestingly, one of the
enzymes that terminates the signal initiated by PI3-K is PTEN, a tumor
suppressor gene, that dephosphorylates the D-3 position of
phosphatidylinositol 3,4,5-trisphosphate. Deficits in either expression
or function of PTEN have been reported in a number of hematological
malignancies (55). PTEN function in Jurkat has not yet been assessed,
but if it is abnormal, then the unopposed basal PI3-K activity could
cause recruitment of Itk to the plasma membrane in the absence of TCR
stimulation. Interestingly, Mills and co-workers (56) have recently
reported that the PI3-K inhibitors wortmannin and LY294002 do not block Itk activation in response to CD3 cross-linking; however, they did not
address the effects of these agents on subcellular distribution of Itk.
It is also possible that the constitutive association of Itk with the
plasma membrane is mediated by the high affinity binding of its
pleckstrin homology domain with PIP2 (57). PIP2 is constitutively present within the GEM fraction of the plasma membrane. Regardless of the mechanism for the constitutive association of Itk with the plasma membrane, recruitment to the plasma membrane is
clearly not sufficient to give Itk activation in Jurkat T cells, because roughly 50% of Itk is recovered from the membrane fraction of
unstimulated cells, in which Itk kinase activity is negligible, and
further recruitment of Itk to the membrane could not be detected under
conditions that cause increased Itk activity.
We propose a working model for Itk activation wherein ZAP-70-initiated
tyrosine phosphorylation events are required for the recruitment of
additional signaling proteins into the GEMs, in particular proteins
that are capable of competitively disrupting the intramolecular
association of the Tec homology and Src homology 3 domains of Itk,
stimulating Itk activation (32). Proteins likely to be important for
this process would be Lat and SLP-76, both of which are involved in
forming multimolecular complexes in response to becoming
tyrosine-phosphorylated. Our observations that Itk undergoes a TCR
engagement-inducible association with Lat and that Itk activation
requires Lat expression suggest that Lat might be acting in a
ZAP-70-dependent manner to co-localize Itk and its
activation partners within the GEM fraction of the plasma membrane.
In conclusion, this represents the first report that the ZAP-70 PTK can
regulate the activity of another protein tyrosine kinase. The
regulation of Itk by ZAP-70 does not appear to require direct
phosphorylation of Itk by ZAP-70. Rather, ZAP-70 indirectly regulates
Itk activation, possibly by phosphorylating Lat. We also demonstrate
that Lat is required for TCR-stimulated Itk activation and demonstrate
that Lat and Itk undergo an inducible association in response to CD3
cross-linking. The facts that this association 1) is induced upon CD3
cross-linking, 2) occurs with kinetics similar to those of Itk tyrosine
phosphorylation and activation, and 3) requires ZAP-70 are consistent
with this association being required for Itk activation and with this
being the site of action of ZAP-70 in the signaling pathway leading to
Itk activation. Additional studies will be needed to more fully address
the requirement for ZAP-70 and Lat in Itk activation and the nature of
the association between Lat and Itk. Additionally, we report finding no
evidence to support the plasma membrane recruitment model for the
activation of Itk in Jurkat T cells in response to TCR engagement. It
will first be necessary to confirm these results in normal T cells before we can assess whether or not this finding is peculiar to the
Jurkat T cell line, or whether this reflects the possibility that
different Tec family proteins are regulated by different mechanisms in
different cell types.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
,
, and
) and TCR
subunits of
the TCR/CD3 complex (3, 4). The doubly phosphorylated immunoreceptor
tyrosine-based activation motifs recruit the Syk family PTK ZAP-70 to
the TCR via interaction with the tandem Src homology 2 domains of
ZAP-70 (5). Recruitment to the TCR is required for the subsequent
tyrosine phosphorylation and activation of ZAP-70 (6, 7).
1, Grb2, and PI3-K to the GEMs (14, 17). The GEM
membrane lipid rafts have been proposed to serve as platforms for
signal transduction upon TCR engagement (18, 19). Localization of
PLC
1 and PI3-K to the GEMs positions these enzymes near their shared
substrate, phosphatidylinositol 4,5-biphosphate, which is enriched in
the GEM fraction, and may facilitate the tyrosine phosphorylation of
PLC
1. Grb2/SOS recruitment to the GEMs also serves to position SOS
in the vicinity of its substrate, Ras, which is constitutively targeted
to the GEMs (20).
1
tyrosine phosphorylation, inositol trisphosphate production, and
Ca2+ influx in response to TCR cross-linking (31).

subunits has also been reported
(34), but it remains unclear whether this plays any role in
TCR-stimulated Itk activation. Experiments involving overexpression of
Itk and c-Src in COS-7 cells demonstrated a requirement for PI3-K in
recruiting Itk to the plasma membrane, where it became phosphorylated
and activated by c-Src (35). Likewise, in A20 B cells, overexpression
of the catalytic subunit of PI3-K was demonstrated to synergize with
Btk, Itk, or Tec overexpression in stimulating IP3 production and the
rise of [Ca2+]i in response to B cell antigen
receptor cross-linking (36).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-glycerophosphate, 2 mM EGTA, 10 mM sodium fluoride, 1 mM sodium orthovanadate, 10% glycerol, 10 µg/ml
leupeptin, 10 µg/ml aprotinin, 100 µg/ml
4-(2-aminoethyl)-benzenesulfonyl fluoride). After a 30-min incubation
on ice, postnuclear lysates were prepared by a 10-min centrifugation at
4 °C, 21,000 × g. The lysates were either directly
analyzed by Western blotting or subjected to immunoprecipitation
followed by immunoblotting or kinase assay. In some experiments, when
indicated, a Brij 96 lysis buffer was used (1% Brij 96, 150 mM NaCl, 25 mM Tris-HCl (pH 7.5), 5 mM EDTA, 10 mM sodium fluoride, 1 mM sodium orthovanadate, 10 µg/ml leupeptin, 10 µg/ml
aprotinin, 100 µg/ml 4-(2-aminoethyl)-benzenesulfonyl fluoride).
-32P]ATP, and 5 µg of RR-SRC substrate
peptide (Sigma) were added. The reaction was performed at room
temperature for 15 min with frequent mixing, then terminated by
addition of acetic acid to 30% of the total volume. The reactions were
centrifuged briefly and supernatants were spotted onto p81
phosphocellulose discs (Life Technologies, Inc.). After 4-6 washes
with 75 mM phosphoric acid, the 32P
incorporation was measured by liquid scintillation. In some assays, the
kinase activity was normalized to the relative amount of Itk recovered
in the anti-Itk immunoprecipitates. The relative amount of Itk was
measured by densitometric analysis of x-ray films using the public
domain NIH Image program (developed at the National Institutes of Health).
-32P]ATP). The
reaction was terminated by the addition of 10 µl of 4× reducing
sample buffer and heating to 100 °C for 5 min. Phosphorylated proteins were resolved by SDS-PAGE and subjected to autoradiography. The GST fusion proteins containing the kinase domains of either Itk or
Lck were purified from recombinant insect cells as described previously
(45). The Itk-KD was cleaved away from the GST fusion partner by
proteolytic cleavage with thrombin, and the GST fragment removed.
Several of the preparations of Itk-KD prepared in this manner were
found to have low intrinsic kinase activity, although they migrated
normally on the gel. One of these low activity preparations was used as
a substrate in the assay. The use of cdb3 as a ZAP-70 substrate has
been described (6). The ZAP-70 enzyme used in this assay was
immunoprecipitated from activated (3 min at 37 °C with 1:100 OKT3)
Jurkat whole-cell lysates that were depleted of Lck by three rounds of
preclearing with antiserum recognizing Lck. The Lck enzyme used in the
assay was the GST-Lck-KD fusion protein, which has been previously
described (45).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (31K):
[in a new window]
Fig. 1.
ZAP-70 is required for tyrosine
phosphorylation and activation of Itk during TCR signaling. Jurkat
and P116 T cells were stimulated with OKT3 ascites at 37 °C for the
times indicated, and Itk immunoprecipitates were prepared from
107 cell equivalents of CD3/Lck-cleared postnuclear lysates
and subjected either to immunoblotting (A) or to an in
vitro kinase assay (B). A, portions of the
Itk immunoprecipitates were resolved on a 6% Tris-glycine gel,
transferred to nitrocellulose and immunoblotted for phosphotyrosine
(4G10), stripped, and blotted for Itk (2F12). B, kinase
activity was determined by measuring the tyrosine phosphorylation of an
exogenous substrate, RR-SRC (as described under "Experimental
Procedures"). S.E. for triplicate samples is shown as error
bars along the y axis. Where error bars are
not apparent, the symbol is larger than the error
bars.

View larger version (40K):
[in a new window]
Fig. 2.
Expression of wild type ZAP-70 in P116 cells
restores the phosphorylation and activation of Itk induced by TCR
stimulation. A, Jurkat, P116, and P.WT18 were either
unstimulated (Unstim.) or stimulated (OKT3) with
OKT3 for 45 s at 37 °C. 107 cell equivalents of Itk
immunoprecipitates or normal rabbit serum (NRS)
immunoprecipitates from CD3-depleted lysates were subjected to an
in vitro, kinase assay as in Fig. 1. S.E. for triplicate
samples is indicated as error bars along the y
axis. B, portions of the Itk immunoprecipitates were
resolved on a 6% Tris-glycine gel, transferred to nitrocellulose, and
immunoblotted for phosphotyrosine (bottom panel). Whole-cell
lysates were resolved on a 4-12% Nu-PAGE gel in MOPS buffer,
transferred to nitrocellulose, and immunoblotted for ZAP-70 (top
panel).

View larger version (83K):
[in a new window]
Fig. 3.
The Itk kinase domain is not an in
vitro substrate of ZAP-70. An in vitro
kinase assay was carried out with the combination of kinases and
substrates indicated, as described under "Experimental Procedures."
The kinases were either ZAP-70, immunoprecipitated from 107
cell equivalents of OKT3-stimulated Jurkat T cells, or purified
recombinant Lck (1 µg). The substrates were either cdb3 (5 µg) or
Itk kinase domain (5 µg). The products of the reaction were resolved
on a 4-12% Nu-PAGE gel and transferred to nitrocellulose, and
32P incorporation was detected by autoradiography.

View larger version (47K):
[in a new window]
Fig. 4.
Itk is constitutively located in GEMs and
exhibits no redistribution with TCR stimulation. Jurkat and P116 T
cells were stimulated with OKT3 for 45 s at 37 °C.
A, cytosolic (C) and membrane (M)
fractions, prepared as described under "Experimental Procedures,"
were either resolved on a 4-12% Nu-PAGE gel (top panel) or
subjected to immunoprecipitation for Itk and analyzed on a 6%
Tris-glycine gel (bottom panel), transferred to
nitrocellulose, and immunoblotted for Itk (2F12). B, GEMs
were prepared by sucrose gradient ultracentrifugation of 1% Triton
X-100 cell homogenates (see under "Experimental Procedures").
Fractions 1, 3, and 10 were resolved on a 4-12%
Nu-PAGE gel, transferred to nitrocellulose, and immunoblotted for Itk
(top panel) and Lat (bottom panel).
1, and Vav can be recovered from the GEMs following TCR
stimulation (17, 18, 20). To test whether TCR cross-linking induces a
shift of Itk into the GEM fraction of the plasma membrane, GEM
preparations were made by sucrose gradient ultracentrifugation as
previously reported (49), and the Itk present in fractions 1 (top of
gradient), 3 (GEMs), and 10 (Triton X-100 soluble fraction) from the
sucrose gradient were assessed by immunoblotting. Itk was present in
both the GEMs and the bulk membrane fractions, and the net distribution of Itk between these fractions did not change upon CD3 cross-linking (Fig. 4B, top panel). This same pattern was observed in both
Jurkat and the ZAP-70-negative P116 cells. This argues against the
regulatory role of ZAP-70 in Itk activation being one of regulating
recruitment to the GEMs, because Itk is constitutively present in the
GEMs and shows no net recruitment to the GEMs under conditions that lead to Itk activation. Furthermore, there is no difference between Jurkat and P116 with regard to the Itk distribution to the GEMs, whereas there are clear differences with regard to Itk activation in
response to OKT3 in these two cell lines. That comparable cell equivalents were loaded from the unstimulated and OKT3-stimulated samples was determined by immunoblotting the same membrane for Lat, the
distribution of which between bulk and GEM membrane fraction is not
believed to change during the course of the 45-s incubation with OKT3
(Fig. 4B, bottom panel).
1, PI3-K, Vav, SLP-76, and c-Cbl, recruiting these molecules to
the GEM fraction of the plasma membrane (14, 17). In addition,
Lat-deficient Jurkat T cells (JCaM2.5) have been reported to be
defective in TCR-mediated signaling, including a failure to induce
tyrosine phosphorylation of PLC
1 or Ca2+ mobilization
(43). Given that both Lat and Itk are involved in regulating
TCR-induced Ca2+ influx, and that Lat is a known substrate
of ZAP-70, we investigated whether or not Lat is required for Itk
activation in response to CD3 cross-linking. This was approached by
using the JCaM2.5 Jurkat T cell line and the JCaM2.5B3,
Lat-reconstituted line (43). However, this analysis was complicated by
the observation that both of these cell lines exhibit deficient Itk
expression as compared with Jurkat cells, as can be seen in Itk blots
of whole cell lysates and Itk immunoprecipitates (Fig.
5A). There is approximately 8 times less Itk in JCaM2.5 and 2 times less Itk in JCaM2.5B3 compared with Jurkat. Therefore, the number of cell equivalents used in subsequent experiments examining Itk tyrosine phosphorylation and
kinase activity were adjusted accordingly to ensure recovery of
comparable levels of Itk in the immunoprecipitates. As described previously, Lat expression is very low in JCaM2.5 and is restored by
stable expression of an epitopically tagged Lat in JCaM2.5B3, as shown
in Lat blots of whole cell lysates (Fig. 5A). Jurkat, JCaM2.5, and JCaM2.5B3 cells were stimulated for 0, 1, or 10 min by
CD3-cross-linking with OKT3. The fold increase in the kinase activity
of Itk was measured in Itk immunoprecipitates and normalized for the
amount of Itk recovered in the immunoprecipitations (Fig. 5B). CD3 cross-linking induced strong activation of Itk
kinase activity in Jurkat and JCaM2.5B3 cells but only weakly activated Itk in JCaM2.5 cells, consistent with Lat playing an important role in
Itk activation. The tyrosine phosphorylation status of the
immunoprecipitated Itk correlated well with the OKT3-induced kinase
activity (Fig. 5C, top panel). The amount of Itk recovered in the Itk immunoprecipitates is shown in the bottom panel
of Fig. 5C.

View larger version (33K):
[in a new window]
Fig. 5.
Lat is required for Itk kinase activity and
phosphorylation. A, 2 × 105 cell
equivalents of the whole-cell lysates or 5 × 106 cell
equivalents of the immunoprecipitates of Itk from unstimulated Jurkat,
JCaM2.5, and JCaM2.5.B3 cells were resolved on a 4-12% Nu-PAGE gel
and blotted for Itk (top panel) and Lat (bottom
panel). B, the three cell lines were stimulated with
OKT3 at 37 °C for the times indicated. Itk was immunoprecipitated
from the Lck and CD3 predepleted whole-cell lysates. 3 µl of the
antiserum was used for 1 × 107 Jurkat, 4 × 107 JCaM2.5, 2 × 107 JCaM2.5.B3 cells.
5 × 106, 4 × 107, and 1 × 107 cell equivalents of Jurkat, JCaM2.5, and JCaM2.5.B3,
respectively, were used in the in vitro Itk kinase assay
(see under "Experimental Procedures"). Each sample was assayed in
triplicate, and the average cpm was normalized to the amount of Itk
protein. The Itk kinase activity was plotted as fold increase upon OKT3
stimulation over unstimulated. C, the same samples of the
immunoprecipitates as in B were resolved on a 6%
Tris-glycine gel (top panel) and a 4-12% Nu-PAGE gel
(bottom panel) and blotted for phospho-tyrosine (4G10) and
Itk (2F12), respectively.
1, c-Cbl, Vav, and SLP-76
with Lat, also found an unidentified tyrosine-phosphorylated protein of
70 kDa. These researchers found that this protein was not ZAP-70 nor
SAM-68. Our results suggest that this protein is likely to be Itk. A
longer exposure (not shown) of the membrane in the top panel
of Fig. 6A could detect some basal association between Lat and Itk in unstimulated Jurkat T cells but still revealed no
association between these two proteins in OKT3-stimulated P116 cells.
Equal or greater amounts of Lat were recovered in the anti-Lat
immunoprecipitations from the P116 cells, as compared with
immunoprecipitations from Jurkat cells (Fig. 6A, bottom
panel), and the anti-Lat antiserum was found to be depleting under
the conditions used in this experiment (not shown). In a similar
experiment, we examined the tyrosine phosphorylation status of Lat in
OKT3-stimulated Jurkat and P116 cells. As reported previously Lat is
rapidly tyrosine-phosphorylated in Jurkat T cells following CD3
cross-linking (14); however, Lat tyrosine phosphorylation was deficient
in P116 cells receiving the same stimulus (Fig. 6B). The
amount of the Lat present in the immunoprecipitates is shown in the
bottom panel of Fig. 6B.

View larger version (54K):
[in a new window]
Fig. 6.
CD3 cross-linking induces an association
between Itk and tyrosine-phosphorylated Lat. Jurkat and P116 T
cells were stimulated with OKT3 for the times indicated at 37 °C.
Lat was immunoprecipitated with a rabbit polyclonal antiserum (3023)
from 1% Brij 96 lysate (see under "Experimental Procedures").
A, 2 × 105 cell equivalents of whole cell
lysates (WCL) or 1 × 107 cell equivalents
of Lat immunoprecipitates were resolved on a 6% Tris-glycine gel,
transferred onto nitrocellulose, and immunoblotted for Itk with mouse
mAb 2F12 (top panel). The anti-Lat immunoprecipitated
samples are over-exposed relative to the whole cell lysate samples. The
same samples were resolved on a 4-12% Nu-PAGE gel and immunoblotted
for Lat (3023) (bottom panel). The whole cell lysate samples
are overexposed relative to the anti-Lat immunoprecipitates.
B, 5 × 106 cell equivalents of Lat
immunoprecipitate was resolved on a 4-12% Nu-PAGE gel, transferred to
nitrocellulose, and blotted for phospho-tyrosine (4G10) (top
panel) and then stripped and blotted for Lat (3023) (bottom
panel).
isoform of the p85 (and the p55 and p50 splice variants) regulatory subunit of PI3-K on lymphocyte development and
responsiveness to antigen found that the p85 knockout mice had impaired
B cell development but perfectly normal T cell development (53, 54). Although the ability of Itk within the T cells isolated from these mice
to undergo activation in response to TCR engagement has not been
reported, it is presumably normal, because these T cells demonstrate
normal responsiveness to TCR stimulation (53). This argues against
pleckstrin homology domain-mediated recruitment of Itk to the plasma
membrane in T cells in response to PI3-K activation as playing a role
in T cell development and function. However, it remains possible that
the
isoform of PI3-K p85 may be more important in T cell function
and that this is compensating for the loss of p85
in T cells
isolated from these mice.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Drs. R. Abraham, R. Aebersold, L. Berg, G. Mills, L. Samelson, J. Watts, and A. Weiss for their gifts of reagents. We also thank Drs. S. Bunnell, J. van Leeuwen, D. McVicar, and W. Zhang for many useful conversations and their critical review of the manuscript.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: NIA, National
Institutes of Health, IRP, Gerontology Research Center, Box 12, 5600 Nathan Shock Dr., Baltimore, MD 21224-6825. Tel.: 410-558-8054; Fax:
410-558-8107; E-mail: wanger@grc.nia.nih.gov.
2 W. Zhang, R. Tribble, and L. E. Samelson, unpublished results.
3 M. J. Czar and P. L. Schwartzberg, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
TCR, T cell antigen
receptor;
Itk, interleukin-2-inducible T cell kinase;
Btk, Bruton's
tyrosine kinase;
Lat, linker for activation of T cells;
PI3-K, phosphatidylinositol 3-kinase;
PLC
1, phospholipase C
;
GEM, glycolipid-enriched membrane;
PTK, protein tyrosine kinase;
GST, glutathione S-transferase;
PAGE, polyacrylamide gel
electrophoresis;
KD, kinase domain;
MOPS, 4-morpholinepropanesulfonic
acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bolen, J. B., and Brugge, J. S. (1997) Annu. Rev. Immunol. 15, 371-404[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Qian, D., and Weiss, A. (1997) Curr. Opin. Cell Biol. 9, 205-212[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Iwashima, M.,
Irving, B. A.,
van Oers, N. S.,
Chan, A. C.,
and Weiss, A.
(1994)
Science
263,
1136-1139 |
| 4. |
van Oers, N. S.,
Killeen, N.,
and Weiss, A.
(1996)
J. Exp. Med.
183,
1053-1062 |
| 5. |
Wange, R. L.,
Malek, S. N.,
Desiderio, S.,
and Samelson, L. E.
(1993)
J. Biol. Chem.
268,
19797-19801 |
| 6. |
Wange, R. L.,
Isakov, N.,
Burke, T. R., Jr.,
Otaka, A.,
Roller, P. P.,
Watts, J. D.,
Aebersold, R.,
and Samelson, L. E.
(1995)
J. Biol. Chem.
270,
944-948 |
| 7. |
Qian, D.,
Mollenauer, M. N.,
and Weiss, A.
(1996)
J. Exp. Med.
183,
611-620 |
| 8. |
Williams, B. L.,
Schreiber, K. L.,
Zhang, W.,
Wange, R. L.,
Samelson, L. E.,
Leibson, P. J.,
and Abraham, R. T.
(1998)
Mol. Cell. Biol.
18,
1388-1399 |
| 9. | Wange, R. L., and Samelson, L. E. (1996) Immunity. 5, 197-205[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Koretzky, G. A. (1997) Immunol. Today 18, 401-406[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Rudd, C. E. (1998) Curr Biol 8, R805-R808[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Wardenburg, J. B.,
Fu, C.,
Jackman, J. K.,
Flotow, H.,
Wilkinson, S. E.,
Williams, D. H.,
Johnson, R.,
Kong, G.,
Chan, A. C.,
and Findell, P. R.
(1996)
J. Biol. Chem.
271,
19641-19644 |
| 13. | Raab, M., da Silva, A. J., Findell, P. R., and Rudd, C. E. (1997) Immunity. 6, 155-164[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Zhang, W., Sloan-Lancaster, J., Kitchen, J., Trible, R. P., and Samelson, L. E. (1998) Cell 92, 83-92[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Wu, J., Motto, D. G., Koretzky, G. A., and Weiss, A. (1996) Immunity. 4, 593-602[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Yablonski, D.,
Kuhne, M. R.,
Kadlecek, T.,
and Weiss, A.
(1998)
Science
281,
413-416 |
| 17. | Zhang, W., Trible, R. P., and Samelson, L. E. (1998) Immunity 9, 239-246[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Montixi, C., Langlet, C., Bernard, A. M., Thimonier, J., Dubois, C., Wurbel, M. A., Chauvin, J. P., Pierres, M., and He, H. T. (1998) EMBO J. 17, 5334-5348[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Moran, M., and Miceli, M. C. (1998) Immunity 9, 787-796[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Xavier, R., Brennan, T., Li, Q., McCormack, C., and Seed, B. (1998) Immunity 8, 723-732[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Rawlings, D. J.,
Saffran, D. C.,
Tsukada, S.,
Largaespada, D. A.,
Grimaldi, J. C.,
Cohen, L.,
Mohr, R. N.,
Bazan, J. F.,
Howard, M.,
Copeland, N. G.,
Jenkins, N. A.,
and Witte, O. N.
(1993)
Science
261,
358-361 |
| 22. | Conley, M. E., and Rohrer, J. (1995) Clin. Immunol. Immunopathol. 76, S192-S197[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Rawlings, D. J., and Witte, O. N. (1995) Semin. Immunol. 7, 237-246[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Siliciano, J. D.,
Morrow, T. A.,
and Desiderio, S. V.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
11194-11198 |
| 25. |
Gibson, S.,
Leung, B.,
Squire, J. A.,
Hill, M.,
Arima, N.,
Goss, P.,
Hogg, D.,
and Mills, G. B.
(1993)
Blood
82,
1561-1572 |
| 26. | Tanaka, N., Asao, H., Ohtani, K., Nakamura, M., and Sugamura, K. (1993) FEBS Lett. 324, 1-5[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
August, A.,
Gibson, S.,
Kawakami, Y.,
Kawakami, T.,
Mills, G. B.,
and Dupont, B.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
9347-9351 |
| 28. | Gibson, S., August, A., Kawakami, Y., Kawakami, T., Dupont, B., and Mills, G. B. (1996) J. Immunol. 156, 2716-2722[Abstract] |
| 29. | Tanaka, N., Abe, H., Yagita, H., Okumura, K., Nakamura, M., and Sugamura, K. (1997) Eur. J. Immunol. 27, 834-841[Medline] [Order article via Infotrieve] |
| 30. | Liao, X. C., and Littman, D. R. (1995) Immunity 3, 757-769[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Liu, K. Q.,
Bunnell, S. C.,
Gurniak, C. B.,
and Berg, L. J.
(1998)
J. Exp. Med.
187,
1721-1727 |
| 32. | Andreotti, A. H., Bunnell, S. C., Feng, S., Berg, L. J., and Schreiber, S. L. (1997) Nature 385, 93-97[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Heyeck, S. D.,
Wilcox, H. M.,
Bunnell, S. C.,
and Berg, L. J.
(1997)
J. Biol. Chem.
272,
25401-25408 |
| 34. |
Langhans-Rajasekaran, S. A.,
Wan, Y.,
and Huang, X. Y.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8601-8605 |
| 35. |
August, A.,
Sadra, A.,
Dupont, B.,
and Hanafusa, H.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11227-11232 |
| 36. | Scharenberg, A. M., El-Hillal, O., Fruman, D. A., Beitz, L. O., Li, Z., Lin, S., Gout, I., Cantley, L. C., Rawlings, D. J., and Kinet, J. P. (1998) EMBO J. 17, 1961-1972[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Rameh, L. E.,
Arvidsson, A.,
Carraway, K. L., III,
Couvillon, A. D.,
Rathbun, G.,
Crompton, A.,
VanRenterghem, B.,
Czech, M. P.,
Ravichandran, K. S.,
Burakoff, S. J.,
Wang, D.-S.,
Chen, C.-S.,
and Cantley, L. C.
(1997)
J. Biol. Chem.
272,
22059-22066 |
| 38. |
Kawakami, Y.,
Yao, L.,
Miura, T.,
Tsukada, S.,
Witte, O. N.,
and Kawakami, T.
(1994)
Mol. Cell. Biol.
14,
5108-5113 |
| 39. |
Li, Z.,
Wahl, M. I.,
Eguinoa, A.,
Stephens, L. R.,
Hawkins, P. T.,
and Witte, O. N.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13820-13825 |
| 40. | Bolland, S., Pearse, R. N., Kurosaki, T., and Ravetch, J. V. (1998) Immunity 8, 509-516[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Griffith, C. E.,
Zhang, W.,
and Wange, R. L.
(1998)
J. Biol. Chem.
273,
10771-10776 |
| 42. | Eischen, C. M., Williams, B. L., Zhang, W., Samelson, L. E., Lynch, D. H., Abraham, R. T., and Leibson, P. J. (1997) J. Immunol. 159, 1135-1139[Abstract] |
| 43. | Finco, T. S., Kadlecek, T., Zhang, W., Samelson, L. E., and Weiss, A. (1998) Immunity 9, 617-626[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Wang, C. C., Badylak, J. A., Lux, S. E., Moriyama, R., Dixon, J. E., and Low, P. S. (1992) Protein Sci. 1, 1206-1214[Abstract] |
| 45. | Watts, J. D., Brabb, T., Bures, E. J., Wange, R. L., Samelson, L. E., and Aebersold, R. (1996) FEBS Lett. 398, 217-222[CrossRef][Medline] [Order article via Infotrieve] |
| 46. | Li, T., Rawlings, D. J., Park, H., Kato, R. M., Witte, O. N., and Satterthwaite, A. B. (1997) Oncogene 15, 1375-1383[CrossRef][Medline] [Order article via Infotrieve] |
| 47. | Simons, K., and Ikonen, E. (1997) Nature 387, 569-572[CrossRef][Medline] [Order article via Infotrieve] |
| 48. | Brown, D. A., and London, E. (1998) Annu. Rev. Cell Dev. Biol 14, 111-136[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Brown, D. A., and Rose, J. K. (1992) Cell 68, 533-544[CrossRef][Medline] [Order article via Infotrieve] |
| 50. |
Stefanova, I.,
Horejsi, V.,
Ansotegui, I. J.,
Knapp, W.,
and Stockinger, H.
(1991)
Science
254,
1016-1019 |
| 51. |
Thomas, P. M.,
and Samelson, L. E.
(1992)
J. Biol. Chem.
267,
12317-12322 |
| 52. | Bohuslav, J., Cinek, T., and Horejsi, V. (1993) Eur. J. Immunol. 23, 825-831[Medline] [Order article via Infotrieve] |
| 53. |
Fruman, D. A.,
Snapper, S. B.,
Yballe, C. M.,
Davidson, L., Yu, J. Y.,
Alt, F. W.,
and Cantley, L. C.
(1999)
Science
283,
393-397 |
| 54. |
Suzuki, H.,
Terauchi, Y.,
Fujiwara, M.,
Aizawa, S.,
Yazaki, Y.,
Kadowaki, T.,
and Koyasu, S.
(1999)
Science
283,
390-392 |
| 55. |
Sakai, A.,
Thieblemont, C.,
Wellmann, A.,
Jaffe, E. S.,
and Raffeld, M.
(1998)
Blood
92,
3410-3415 |
| 56. |
Lu, Y.,
Cuevas, B.,
Gibson, S.,
Khan, H.,
LaPushin, R.,
Imboden, J.,
and Mills, G. B.
(1998)
J. Immunol.
161,
5404-5412 |
| 57. | Harlan, J. E., Hajduk, P. J., Yoon, H. S., and Fesik, S. W. (1994) Nature 371, 168-170[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |